New embryo genetic test aims to cut miscarriages and birth defects
NCT ID NCT07533630
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will test an upgraded genetic test (PGT-A upgrade) on embryos from 1,700 IVF patients across multiple countries. The test looks for a wider range of chromosomal issues than standard tests. Researchers hope this will help select healthier embryos, reducing the chance of miscarriage and birth defects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PGT-A upgrade genetic test
What this could lead to
If successful, this could improve embryo selection in IVF, potentially lowering miscarriage and birth defect rates.
What could go wrong
This is an observational study, not a treatment trial. It may not directly improve pregnancy outcomes, and results may take years to apply clinically.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILITY ASSISTED REPRODUCTIVE TECHNOLOGY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Biocódices
Buenos Aires, Argentina
Contact Email: •••••@•••••
Contact
-
CITIC-Xiangya Reproductive & Genetic Hospital
Changsha, Hunan, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
First People's Hospital of Yunnan Province
Kunming, Yunnan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Institute Bernabéu
Alicante, Spain
Contact Email: •••••@•••••
Contact
-
Miracle
Daegu, South Korea
Contact Email: •••••@•••••
Contact
-
Nanjing Women and Children's Healthcare Hospital
Nanjing, Jiangsu, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Thomson Hospital
Petaling Jaya, Malaysia
Contact Email: •••••@•••••
Contact